Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea

Main Article Content

Neal Bhatia
Edward Lain
Hilary Baldwin
Sam Brantman
James Del Rosso
Raja Sivamani

Keywords

rosacea

Abstract

N/A

References

1. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris
[published correction appears in J Am Acad Dermatol. 2020;82(6):1576]. J Am Acad Dermatol.
2016;74(5):945-973. [Table V pg. 951; p. 951 col1, p3; p951 col2p2.]

2. Brammann C, Müller-Goymann CC. Int J Pharm. 2020;578:119074. [pg2, col 2, para3; pg 7 Table 1; pg 9
col 1 para 1; pg 9 col 2 para 4; pg 6 col 1 para 5; pg 6 col 2 para 5]

3. Kolli S, Pecone D, Pona A, et al. Topical retinoids in acne vulgaris: a systematic review. Am J Clin
Dermatol 2019;20(3):345-365. [pg 345 Abstract; pg 346 col 1, para 1; pg 362, col 2 para2; pg 362 col 1
para 3- col 2 para 1]

4. Oztürkcan S, Ermertcan AT, Sahin MT, Afşar FS. Efficiency of benzoyl peroxide-erythromycin gel in
comparison with metronidazole gel in the treatment of acne rosacea. J Dermatol. 2004 Aug;31(8):610-7.
doi: 10.1111/j.1346-8138.

5. Erlich M, Arie T, Koifman N, et al. Structure elucidation of silica-based core-shell microencapsulated
drugs for topical applications by cryogenic scanning electron microscopy. J Colloid Interface Sci. 2020
Nov 1;579:778-785. doi: 10.1016/j.jcis.2020.06.114.

Most read articles by the same author(s)

1 2 3 4 5 6 > >>